Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Merck announces Molnupiravir manufacturing in Canada for COVID-19
Merck announces Molnupiravir manufacturing in Canada for COVID-19
Merck announces Molnupiravir manufacturing in Canada for COVID-19
Standard Video
Actions
Overview
Conceptually Similar Documents
CP143756471 | Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19
CP17178065 | Canada's $850M promise for international COVID-19 fight 'only a beginning'
CP160599428 | Health Canada approves first COVID-19 vaccine for children under five
CP115594721 | Ford appeals to Biden for COVID-19 vaccines
CP141789821 | Health Canada approves first COVID-19 vaccine for kids aged five to 11
CP142139971 | Plane carrying COVID-19 vaccines for kids touches down in Canada
CP19569371 | Canada buys options for fifth potential COVID-19 vaccine
CP111820571 | National plans for COVID-19 vaccine distribution in the works: Hajdu
CP114035121 | 'We are headed in a good direction:' Manitoba announces 133 new COVID-19 cases
CP142525721 | Child COVID-19 vaccinations ramp up in Ontario
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
Merck announces Molnupiravir manufacturing in Canada for COVID-19
Source name:
The Canadian Press
Unique identifier:
CP143754121
Legacy Identifier:
n_COVID-Treatment20211206T1330
Type:
Video
Duration:
2m46s
Dimensions:
1920px × 1080px 196.41 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
12/6/2021 1:30:00 PM
Display aspect ratio:
16:9
Tags
Coronavirus
COVID-19
Francois-Phillipe Champagne
health
Marwan Akar
Merck
Ontario
oral antiviral medicine
Ryan Turnbull
safety
toronto
treatment
vaccine